NuCana
-$0.46 (-11.83%) Today
$0.00 (0.00%) As of 9:20 AM UTC after-hours
Why Robinhood?
You can buy or sell NuCana and other stocks, options, and ETFs commission-free!
About NCNA
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738.
CEO
Hugh Stephen Griffith
Employees
29
Headquarters
Edinburgh, Midlothian
Founded
1997
NCNA Key Statistics
Market Cap
186.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.77K
High Today
$3.90
Low Today
$3.38
Open Price
$3.87
Volume
581.51K
52 Week High
$7.83
52 Week Low
$3.38
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
NCNA Earnings
-$0.32
-$0.21
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 19, After Hours